Vaxxas

company

About

Vaxxass is a biotechnology company focused on needle-free vaccination technology.

Details

Last Funding Type
Series C
Last Funding Money Raised
$34M
Industries
Biotechnology,Health Care,Medical Device
Founded date
Jan 1, 2011
Number Of Employee
51 - 100
Operating Status
Active
Legal Name
Vaxxas Pty. Ltd
Also Known As
Vaxxas, Inc.

Vaxxass is a biotechnology company that develops a novel needle-free vaccination technology. The company uses proprietary dry-coating technology that can eliminate or significantly reduce the need for vaccine refrigeration during storage and transportation - easing the resource and logistics burden of maintaining the vaccine "cold chain".

Vaxxas was incorporated in 2011 and is based in Brisbane, Australia.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
7
$61.60M $52M
Vaxxas has raised a total of $61.60M $52M in funding over 2 rounds. Their latest funding was raised on Dec 5, 2022 from a Series C round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Dec 5, 2022 Series C $34M 2 OneVentures
UniQuest,
Detail
Sep 20, 2022 Grant $8.20M 1 Australian Government Detail
Jan 1, 2021 Grant $4.40M 1 Australian Government Detail
Oct 5, 2020 Grant $22M 1 Biomedical Advanced Research and Development Authority (BARDA) Detail
Mar 17, 2020 Grant $5M 1 Bill & Melinda Gates Foundation Detail

Employee Profiles

Number of Employee Profiles
10
Vaxxas has 10 current employee profiles, including Board member Paul Kelly
Board member
Board member
Board member
Board member
Executive